These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 31184808)

  • 1. Distribution of cervical lesions in young and older women.
    Díaz Del Arco C; Jiménez Ayala B; García D; Sanabria C; Fernández Aceñero MJ
    Diagn Cytopathol; 2019 Jul; 47(7):659-664. PubMed ID: 31184808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management.
    Rader AE; Rose PG; Rodriguez M; Mansbacher S; Pitlik D; Abdul-Karim FW
    Acta Cytol; 1999; 43(3):357-62. PubMed ID: 10349362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
    Yarandi F; Izadi Mood N; Mirashrafi F; Eftekhar Z
    Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):514-6. PubMed ID: 15598287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynaecological cytology screening in South Australia: a 23-year experience.
    MacCormac L; Lew W; King G; Allen PW
    Med J Aust; 1988 Nov; 149(10):530-6. PubMed ID: 3185322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cervical smears at King Hussein Medical Centre, Jordan, over three and a half years.
    Malkawi SR; Abu Hazeem RM; Hajjat BM; Hajjiri FK
    East Mediterr Health J; 2004; 10(4-5):676-9. PubMed ID: 16335662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia.
    Flynn K; Rimm DL
    Diagn Cytopathol; 2001 Feb; 24(2):132-6. PubMed ID: 11169895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia.
    Elhakeem HA; Al-Ghamdi AS; Al-Maghrabi JA
    Saudi Med J; 2005 Apr; 26(4):588-92. PubMed ID: 15900366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
    Howell LP; Gurusinghe S; Tabnak F
    Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
    Alanen KW; Elit LM; Molinaro PA; McLachlin CM
    Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cervical screening results in a population at normal risk.
    Karabulut A; Alan T; Ali Ekiz M; Iritaş A; Kesen Z; Yahşi S
    Int J Gynaecol Obstet; 2010 Jul; 110(1):40-2. PubMed ID: 20362986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical disease in postmenopausal HIV-1-infected women].
    Ceccaldi PF; Ferreira C; Coussy F; Mechler C; Meier F; Crenn-Hebert C; Mandelbrot L
    J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):466-70. PubMed ID: 20692113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.